The aim of the present study was to assess the estimated "per patient" total cost for a single Oncologic Italian Cancer Center participating in a multicenter clinical trial with new anticancer biological agents using the activity-based costing (ABC) methodology.
Costs of clinical trials with anticancer biological agents in an Oncologic Italian Cancer Center using the activity-based costing methodology / Pascarella, G., Capasso, A., Nardone, A., Triassi, M., Pignata, S., Arenare, L., Ascierto, P., Curvietto, M., Maiolino, P., D'Aniello, R., Montanino, A., Laudato, F., De Feo, G., Botti, G., Perrone, F., Petrillo, A., Cavalcanti, E., Lastoria, S., Maurea, N., Morabito, A.. - In: PLOS ONE. - ISSN 1932-6203. - 14:1(2019), p. e0210330. [10.1371/journal.pone.0210330]
Costs of clinical trials with anticancer biological agents in an Oncologic Italian Cancer Center using the activity-based costing methodology
Pascarella, Giacomo;Capasso, Arturo;Nardone, Antonio;Triassi, Maria;Ascierto, Paolo;Montanino, Agnese;De Feo, Gianfranco;Perrone, Francesco;Cavalcanti, Ernesta;
2019
Abstract
The aim of the present study was to assess the estimated "per patient" total cost for a single Oncologic Italian Cancer Center participating in a multicenter clinical trial with new anticancer biological agents using the activity-based costing (ABC) methodology.| File | Dimensione | Formato | |
|---|---|---|---|
|
Pascarella-2019-Costs-of-clinical-trials-with-antic.pdf
accesso aperto
Tipologia:
Documento in Post-print
Licenza:
Dominio pubblico
Dimensione
1.4 MB
Formato
Adobe PDF
|
1.4 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
